Here are the 50 most-read stories, out of the 3,400 we covered last year in The Digest.
The page view champ this year, clocking in at 17,821 reads — though the “algae fuels” story is starting to look like a verse out of the song “In the year 2525”.
Hands down, the saddest story we ever had to write — written at light-speed, real-time, with a heavy heart. The tributes to Guido would keep flowing in all year.
Algae, algae, algae — we looked at DHA, EPA, fish feed, plastics and even occasionally at fuels.
A perennial favorite — who’s mandaing what, where, and sometimes how and why. The 2014 edition is still popular too, and checked in at #7 for 2014-14 even 18 months past posting date.
BP made news twice this year — first with a report that they would put the cellulosic business up for sale — and then, in January, this report on the timing of the sale and how it would all come to pass. In the end, not much was sold off that we learned about — the business shut down before then end of the first half.
One of the most popular stories was a whodunit starring Roquette and Solazyme — a story we expect to come back to again when the courts fire up again as Solazyme and Roquette move from arbitraiton to the legal docket.
This story on grants to Red Rock, Fulcrum and Emerald Biofuels was the #1 story line for drop in fuels all year.
When the world’s largest upstream petrochemical producer, by profit, invests in biotech — it’s a world turned upside down, right? Well, not really — we go through the whys and wherefores.
The big cellulosic start-up in Brazil drew a tom of global readership.
When oil prices collapsed, this article provided some welcome ideas on potential winners in a world of lower-cost fuels.
One of a couple of articles we wrote in the last year on “Where are the gallons?” — this one went into the detail of why INEOS Bio’s project wasn’t producing at the time, and when a technology upgrade would be delivered that might fix the problem.
When Reliance opted to install an Algenol demonstration project, it was big big news — here’s the skinny.
Curious the readers are on what technologies do well in a world of low oil prices — but curiouser still as to when the bleeding will stop. Here was our take in January as the debacle unfolded.
Another big opening. This one, Abengoa, with a host of big names led by Energy Secretary Ennest Moniz
The Hot 50 announce story had a big storyline this year — LanzaTech toppled Solazyme.
A big opportunity to add to the bottom line for first-gen ethanol is in liquid CO2. Here’s the Aemetis project that undertakes that value-add.
EPA struck hard at advanced biofuels this year, slashing targets and crushing investor confidence. Here’s the sad story of how the EPA transformed into the Emitter’s Protecion Agency.
As companies like BP folded up on cellulosic fuels, Shell amped up the news with this announce that they expect to be producing at commercial-scale by 2019.
A number of cellulosic ethanol projects opened in a flurry in late 2014 – welcome as a cherished baby who delivered later than expected. The who, how and why.
DuPont has been signing licenses even ahead of its first commercial opening. Most recently in China, but here was the first, in Macedonia.
OPX Biotechnologies graced the Hot 30 for some time — troubled by the fall in oil prices and the expected impact on some of its development timelines, they found a willing suitor in Cargill.
The Hot 30 announce story – Genomatica topped than rankings for the 4th year in a row.
Who are the movers and shakerss? Well, here’s our take on the Top 125, which shifted quite a lot this year towards producers, with less emphasis on policymakers and scientists.
Joule — the Stealth Kings of New Mexico — opened the kimono just a little bit here, but the headline “commercial by 2017” caught everyone’s attention.
Each January we set our our predictions for the year, and we’ve made some reasonably good guesses and some real lu-lus over the years. Check them out.
As they might have said in Hawaii 5-0, the Biobased version: Book ‘em, Nano! The weird but increasingly commercially feasible world of nanocellulose. What is it, and why is it getting traction?
Here’s we outed Reliance Industries as they re-upped with Algenol and dropped Aurora — which may well have contributed much to Aurora’s demise some 10 months later.
Coke is it, at least as far a paraxylene goes. Here’s they’re upping the ante from lab-scale to demo-scale, and exhibiting 100% renewable PlantBottles in Milan.
Solazyme’s stock tumbled almost 75% this year, when delays struck at Moema. Here’s the inside scoop.
Our newest ranking, the Hot 40, and Liquid Light is at the top of it, As companies go big in the sector, we introduce a new poll aimed at focusing in on the “small is beautiful” early-stage sector.
Stealth! Who to watch out for in the critical field of getting the water out of the algae, or the algae out of the water.
As if the KiOR story couldn’t get any more interesting, here are steamy documents filed with the SEC detailing a simmercing dispute over the viability of the design.
Carbon Monoxide — you can’t vent it, so why not capture and use it? That’s the LanzaTech story, and my how they are using it to drive value from the EU to CHina.
Here, we debunk a few myths that persist even more pervasively than stories of alligators in the New York sewer system or sightings of Elvis.
Almost as popular as the Hot 30, 40 and Hot 50 results is the opening of voting. Particularly, the Photo Voting which brings out a huge streak of creativity lurking in the industry.
POET-DSM opened and even the King of the Netherlands was on hand to celebrate, in Emmetsburg, Iowa’s most glamorous day, hands down.
Why make a $2 fuel when you can make a $5 chemical? Well, according to the NRC, why not indeed make a chemical, and plenty will they say, creating a Tidal Wave of Opportunity, perhaps?
KiOR’s troubles were abounding by September, and we caught readers up with the latest, here.
Our #1 outside column all year, as Vonnie Estes highlighted a wave of investment in AgTech.
The Congressional Budget Office tipped a world of $6.00 fuels, including all those RIN credits, in this unicorn-laden report.
Research, research and more research, hard data on the markets for renewables drew a big readership this year.
Trash talk! Here we told the story of Enerkem’s first commercial plant in words and pictures, from the opening ceremonies in Edmonton.
Biodiesel – America’s favorite advanced biofuels. What’s up with all those affordable triglyceride oils?
It’ll be open for business in October 2015, but is now mechanically complete — the DuPont cellulosic refinery in Nevada, Iowa. Here’s we profiled the rapid progress in construction.
The DOE has co-sponsored a huge array of pilot and demonstration projects over the years. What are the successes, the failures, the ones that never got off the ground and the ones that beat all expectations?
To some its the Blunder Crop, jatropha that is — but many still see it as a wonder crop in the making. Lots of activity around the world on jatropha 2.0 – here are the highlights.
Thank you for the processing technologies. Where’s all the feedstock? Will we come up ruinously short? Here’s we look at the hard data.
There’s development, which the DOE has been working on hard for years — now, we move into deployment, but what’s the DOE view on timing, players, technologies and the whole shebang?